Telephus Medical Garners $1,400,000 New Funding

  • Feed Type
  • Date
    12/5/2013
  • Company Name
    Telephus Medical
  • Mailing Address
    11011 Torreyana Road San Diego, CA 92121
  • Company Description
    Telephus is developing TPH 101, a first-in-class humanized monoclonal antibody to prevent Staphylococcus reinfection and accompanying osteomyelitis in patients receiving total hip arthroplasty (THA) or total knee arthroplasty (TKA) septic revision surgery.
  • Website
    http://www.telephusmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,400,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    WS Investment
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.